Trevi Therapeutics, Inc. $(TRVI)$ is currently at $4.33, up $1.84 or 73.9%
--Would be highest close since Aug. 21, 2020, when it closed at $4.78
--On pace for largest percent increase since March 31, 2020, when it rose 92.4%
--Currently up three of the past five days
--Up 50.35% month-to-date
--Up 223.14% year-to-date; on pace for best year on record (Based on available data back to May 7, 2019)
--Down 57.21% from its all-time closing high of $10.12 on June 3, 2019
--Up 238.29% from 52 weeks ago (Dec. 14, 2023), when it closed at $1.28
--Would be a new 52-week closing high
--Up 238.29% from its 52-week closing low of $1.28 on Dec. 15, 2023
--Traded as high as $4.60; highest intraday level since Aug. 12, 2022, when it hit $4.60
--Up 84.74% at today's intraday high; largest intraday percent increase since March 31, 2020, when it rose as much as 250.88%
All data as of 1:40:01 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 12, 2024 13:45 ET (18:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.